Severity of allergic rhinitis and asthma development in children

Giuseppe Di Cara1, Alessia Carelli1, Arianna Latini1

  • 1Institute of Pediatrics, Department of Surgical and Biomedical specialty, Perugia, Italy.

Insights

Allergic rhinitis (AR) in children is a significant risk factor for developing asthma. Moderate to severe persistent AR at baseline strongly predicted asthma development within five years.

Area of Science:

  • Pediatric Allergy and Immunology
  • Respiratory Medicine
  • Epidemiology

Background:

  • Allergic rhinitis (AR) is a common childhood condition.
  • AR is recognized as a potential precursor to asthma development.
  • Understanding risk factors for pediatric asthma is crucial.

Purpose of the Study:

  • To investigate the long-term association between allergic rhinitis severity and asthma development in children.
  • To determine if baseline AR severity predicts future asthma diagnosis.

Main Methods:

  • A cohort of 104 children diagnosed with allergic rhinitis was recruited.
  • Participants were followed and re-evaluated after a 5-year period.
  • The ARIA (Allergic Rhinitis and its Impact on Asthma) classification was used to assess rhinitis severity.

Main Results:

  • All children in the cohort with moderate to severe persistent allergic rhinitis at the study's onset developed asthma symptoms.
  • A strong correlation was observed between baseline AR severity and subsequent asthma development.

Conclusions:

  • The severity of allergic rhinitis in children is a critical factor influencing the risk of developing asthma.
  • Early identification and management of moderate to severe AR may be important in preventing pediatric asthma.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
5.0K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K